Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B.
暂无分享,去创建一个
[1] L. Gooding. Virus proteins that counteract host immune defenses , 1992, Cell.
[2] K. Hertogs,et al. Endonexin II, present on human liver plasma membranes, is a specific binding protein of small hepatitis B virus (HBV) envelope protein. , 1993, Virology.
[3] B. Moss,et al. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis , 1995, The Journal of experimental medicine.
[4] F. Chisari,et al. Hepatitis B virus structure and biology. , 1989, Microbial pathogenesis.
[5] F. Schödel,et al. Characterization of self‐reactive T cells that evade tolerance in hepatitis B e antigen transgenic mice , 1995, European journal of immunology.
[6] A Sette,et al. Human class I supertypes and CTL repertoires extend to chimpanzees. , 1998, Journal of immunology.
[7] F. Chisari,et al. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T–lymphocyte response , 1996, Nature Medicine.
[8] J. Hoofnagle,et al. Peroxidase‐anti‐peroxidase detection of hepatitis B surface and core antigen in liver biopsy specimens from patients with chronic type B hepatitis , 1987, Journal of medical virology.
[9] F. Chisari,et al. Noncytopathic Clearance of Lymphocytic Choriomeningitis Virus from the Hepatocyte , 1999, The Journal of experimental medicine.
[10] H. Varmus,et al. The molecular biology of the hepatitis B viruses. , 1987, Annual review of biochemistry.
[11] F. Chisari,et al. La Autoantigen Specifically Recognizes a Predicted Stem-Loop in Hepatitis B Virus RNA , 1999, Journal of Virology.
[12] A. Sette,et al. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells , 1994, Nature.
[13] J. Taylor,et al. Asymmetric replication of duck hepatitis B virus DNA in liver cells: Free minus-strand DNA. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[14] A. Alcamí,et al. Cytokine receptors encoded by poxviruses: a lesson in cytokine biology. , 1995, Immunology today.
[15] K. Sutherland,et al. Hepatitis B virus surface antigen binds to apolipoprotein H , 1994, Journal of virology.
[16] R. Palmiter,et al. Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice , 1986, Journal of virology.
[17] J. Summers,et al. Mapping of the cohesive overlap of duck hepatitis B virus DNA and of the site of initiation of reverse transcription , 1984, Journal of virology.
[18] F. Chisari,et al. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[19] F. Chisari,et al. Hepatitis B virus persistence after recovery from acute viral hepatitis. , 1994, The Journal of clinical investigation.
[20] P. Simmonds. Variability of hepatitis C virus , 1995, Hepatology.
[21] J. Carlson,et al. Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. , 1986, The New England journal of medicine.
[22] J. Hoofnagle,et al. Acute type A hepatitis during chronic hepatitis B virus infection: Association of depressed hepatitis B virus replication with appearance of endogenous alpha interferon , 1984, Journal of medical virology.
[23] F. Chisari,et al. Interleukin-2 downregulates hepatitis B virus gene expression in transgenic mice by a posttranscriptional mechanism. , 1993, Journal of virology.
[24] F. Chisari,et al. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. , 1996, Immunity.
[25] G. Natoli,et al. Hepatitis B virus X gene product acts as a transactivator in vivo. , 1994, Journal of hepatology.
[26] C. Peschle,et al. Transferrin receptor mediates uptake and presentation of hepatitis B envelope antigen by T lymphocytes , 1992, The Journal of experimental medicine.
[27] J. Price,et al. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[28] A. Perelson,et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.
[29] F. Chisari,et al. Strong, sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice , 1995, Hepatology.
[30] F. Chisari,et al. Hepatitis B virus nucleocapsid particles do not cross the hepatocyte nuclear membrane in transgenic mice , 1994, Journal of virology.
[31] V. Pasquetto,et al. Pathogenetic effector function of CD4-positive T helper 1 cells in hepatitis B virus transgenic mice. , 1997, Journal of immunology.
[32] F. Chisari,et al. Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice , 1992, Journal of virology.
[33] F. Zoulim,et al. Woodchuck hepatitis virus X protein is required for viral infection in vivo , 1994, Journal of virology.
[34] F. Chisari,et al. The hepatitis B virus (HBV) precore protein inhibits HBV replication in transgenic mice , 1996, Journal of virology.
[35] M. Mondelli,et al. Significance of the immune response to a major, conformational B-cell epitope on the hepatitis C virus NS3 region defined by a human monoclonal antibody , 1994, Journal of virology.
[36] F. Chisari,et al. Immune Pathogenesis of Hepatocellular Carcinoma , 1998, The Journal of experimental medicine.
[37] A. Sonnenberg,et al. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. , 1985, The New England journal of medicine.
[38] F. Chisari,et al. Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. , 1994, Journal of immunology.
[39] J. Wands,et al. Posttranscriptional regulation of hepatitis B virus replication by the precore protein , 1997, Journal of virology.
[40] A. Hughes,et al. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[41] A. Sette,et al. A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire. , 1994, Journal of immunology.
[42] F. Chisari,et al. Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways , 1994, Journal of virology.
[43] F. Chisari,et al. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice. , 1995, Journal of immunology.
[44] F. Chisari,et al. High-level hepatitis B virus replication in transgenic mice , 1995, Journal of virology.
[45] F. Chisari,et al. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. , 1996, The Journal of clinical investigation.
[46] F. Chisari,et al. Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[47] C. Harris,et al. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[48] P. Galle,et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage , 1995, The Journal of experimental medicine.
[49] D J Moss,et al. Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus , 1994, The Journal of experimental medicine.
[50] T. Friedmann. Molecular Genetic Medicine , 1991 .
[51] F. Chisari,et al. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen , 1991, The Journal of experimental medicine.
[52] J. Summers,et al. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate , 1982, Cell.
[53] R. Palmiter,et al. A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. , 1985, Science.
[54] K. Koike,et al. High‐level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice , 1994, Hepatology.
[55] R. Sprengel,et al. Replication strategy of human hepatitis B virus , 1987, Journal of virology.
[56] F. Chisari,et al. Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection. , 1995, The Journal of clinical investigation.
[57] F. Chisari,et al. Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[58] P. Hofschneider,et al. The hepatitis B virus large surface protein (LHBs) is a transcriptional activator. , 1996, Virology.
[59] J. Carlson,et al. Chronic 'cryptogenic' liver disease and malignant hepatoma in intermediate alpha 1-antitrypsin deficiency identified by a Pi Z-specific monoclonal antibody. , 1985, Scandinavian journal of gastroenterology.
[60] C. Chu,et al. Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier state: a multivariate analysis in a longitudinal follow-up study. , 1994, The Journal of infectious diseases.
[61] B. Walker,et al. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire , 1994, The Journal of experimental medicine.
[62] F. Chisari,et al. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice , 1997, Journal of virology.
[63] F. Chisari,et al. Inhibition of Hepatitis B Virus Replication during Adenovirus and Cytomegalovirus Infections in Transgenic Mice , 1998, Journal of Virology.
[64] F. Chisari,et al. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[65] F. Chisari. Hepatitis B virus biology and pathogenesis. , 1992, Molecular genetic medicine.
[66] R. Miller,et al. Hepatitis B viral DNA-RNA hybrid molecules in particles from infected liver are converted to viral DNA molecules during an endogenous DNA polymerase reaction. , 1984, Virology.
[67] R. Palmiter,et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice , 1989, Cell.
[68] J. Summers,et al. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells , 1986, Cell.
[69] W. Rutter,et al. Assembly of viral particles in Xenopus oocytes: pre-surface-antigens regulate secretion of the hepatitis B viral surface envelope particle. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[70] M. Houghton,et al. Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. , 1990, British medical bulletin.
[71] F. Chisari,et al. Hepatitis B Virus RNA-Binding Proteins Associated with Cytokine-Induced Clearance of Viral RNA from the Liver of Transgenic Mice , 1999, Journal of Virology.
[72] F. Chisari,et al. Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice. , 1990, Cancer research.
[73] D. Green,et al. Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege , 1995, Science.
[74] F. Chisari,et al. Hepatitis B virus immunopathogenesis. , 1995, Annual review of immunology.
[75] P. Hofschneider,et al. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway , 1993, Nature.
[76] P. Marion,et al. Hepadnaviruses and retroviruses share genome homology and features of replication , 1987, Hepatology.
[77] F. Chisari,et al. Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice. , 1992, Cancer research.
[78] F. Chisari,et al. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis , 1993, The Journal of experimental medicine.
[79] R. Palmiter,et al. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[80] J. Hoofnagle,et al. Viral hepatitis and liver disease , 1984 .
[81] J. Altman,et al. Persistence of memory CD8 T cells in MHC class I-deficient mice. , 1999, Science.
[82] Lu-Yu Hwang,et al. HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS A Prospective Study of 22 707 Men in Taiwan , 1981, The Lancet.
[83] H. Varmus,et al. Biochemical and genetic evidence for the hepatitis B virus replication strategy. , 1986, Science.
[84] N. Shastri. Antigen processing and recognition Edited by James McCluskey. Boca Raton: CRC Press. (1991). 257 pp. $139.95 , 1992, Cell.
[85] B. Ames,et al. Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[86] B. Walker,et al. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV , 1993, Journal of virology.
[87] T. Tokino,et al. Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis. , 1990, Molecular biology & medicine.
[88] G. Natoli,et al. Induction of the DNA-binding activity of c-jun/c-fos heterodimers by the hepatitis B virus transactivator pX , 1994, Molecular and cellular biology.
[89] A. Siddiqui,et al. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions , 1991, Science.
[90] W. Mason,et al. Evidence that a capped oligoribonucleotide is the primer for duck hepatitis B virus plus-strand DNA synthesis , 1986, Journal of virology.
[91] R. Palmiter,et al. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. , 1990, Science.
[92] Y. Suzuki,et al. The effect of anti-IFN-gamma antibody on the protective effect of Lyt-2+ immune T cells against toxoplasmosis in mice. , 1990, Journal of immunology.
[93] Y. Miyakawa,et al. A hepatitis B surface antigen polypeptide (P31) with the receptor for polymerized human as well as chimpanzee albumins. , 1983, Gastroenterology.
[94] F. Chisari,et al. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis , 1993, The Journal of experimental medicine.
[95] Persephone Borrow,et al. Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV , 1994, Nature.
[96] B. Woda,et al. Lymphocyte apoptosis during the silencing of the immune response to acute viral infections in normal, lpr, and Bcl-2-transgenic mice. , 1995, The American journal of pathology.
[97] H. Zentgraf,et al. Precore-mediated inhibition of hepatitis B virus progeny DNA synthesis , 1993, Journal of virology.
[98] B. Portmann,et al. Hepatocellular carcinoma in the non-cirrhotic liver: a comparison with that complicating cirrhosis. , 1984, The Quarterly journal of medicine.
[99] Xiping Wei,et al. Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus , 1997, Nature Medicine.
[100] B. Walker,et al. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. , 1995, The Journal of clinical investigation.
[101] A. Vitiello,et al. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. , 1993, Journal of immunology.
[102] M. Gerber,et al. Cytoplasmic hepatitis B antigen in "ground-glass" hepatocytes of carriers. , 1973, Archives of pathology.
[103] J. Wands,et al. Carboxypeptidase D Is an Avian Hepatitis B Virus Receptor , 1999, Journal of Virology.
[104] W. Caselmann,et al. Hepatitis B virus transactivator MHBst: activation of NF‐kappa B, selective inhibition by antioxidants and integral membrane localization. , 1992, The EMBO journal.
[105] G. Jay,et al. HBx gene of hepatitis B virus induces liver cancer in transgenic mice , 1991, Nature.
[106] F. Chisari,et al. Transmission of type B viral hepatitis to chimpanzees. , 1973, The Journal of infectious diseases.
[107] P. Klenerman,et al. Persistence of lymphocytic choriomeningitis virus at very low levels in immune mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[108] W. Fleig,et al. Hepatocellular carcinoma in type I glycogen storage disease , 1988, Hepatology.
[109] M. Rehli,et al. Identification of a membrane-bound carboxypeptidase as the mammalian homolog of duck gp180, a hepatitis B virus-binding protein. , 1997, Life sciences.